EMEA-001915-PIP01-15-M03
Key facts
Invented name |
Waylivra
|
Active substance |
Volanesorsen
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0131/2021
|
PIP number |
EMEA-001915-PIP01-15-M03
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of familial chylomicronemia syndrome
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Akcea Therapeutics
Tel. +1 6172070202 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|